Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Maytansinoid-conjugated human monoclonal antibody against mesothelin

EU orphan designation number: EU/3/12/1073   
Active ingredient: Maytansinoid-conjugated human monoclonal antibody against mesothelin
Indication: Treatment of malignant mesothelioma
Sponsor: Bayer AG
D-51368 Leverkusen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/12/2012 Orphan designation EMA/OD/063/12 (2012)9392 of 06/12/2012
21/08/2017 Transfer of orphan designation EMA/OD/063/12/T/01 (2017)5797 of 17/08/2017